BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2021-04-07 凯凯凯迪拉克

4.3投稿，2100+，祝愿自己中中中，中了来还愿

88 33

展开33条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2021-02-04 woyaofascisci

12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投

220 32

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2023-12-05 ms5000001058303842 来自北京

偏重的研究方向：分子生物学
经验分享：请问现在送审到多少号啦？我是7434#期刊论坛#

79 31

展开31条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2020-12-31 qingzhe1988

9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！

119 31

展开31条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2023-02-28 ms3000001512295561 来自天津

审稿速度:1.0
偏重的研究方向：离子通道;毒理学
经验分享：实时更新
2.14 submitted to journal
2.21 under review
2.28 under review

75 29

展开29条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2021-09-07 叮咚_MH

偏重的研究方向：自噬
经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急

85 29

展开29条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2021-02-25 ms2205852206988122

审稿速度:1.0
经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。

187 28

展开28条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2020-05-05 12147f1dm17暂无昵称

24小时内接受了，果然是神刊！

267 26

展开26条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2023-01-12 ms6000001140416710 来自北京

9号投了，还在Submitted to Journal，大家最近投的怎么样了

111 26

展开26条回复

[GetPortalCommentsPageByObjectIdResponse(id=955035, encodeId=71ee95503503, content=4.3投稿，2100+，祝愿自己中中中，中了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dfe2457935, createdName=凯凯凯迪拉克, createdTime=Wed Apr 07 20:37:42 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922716, encodeId=64b0922e167c, content=12月20投稿，1月21日send back要求提交WB原始图，1月23日按照要求提交，2月2日under review，2月3日接收，但要求润色， Before publication I request revision of the English laguage。不知道是要自己去润色，还是编辑会帮忙修改。谢谢神刊，毕业值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29e42307580, createdName=woyaofascisci, createdTime=Thu Feb 04 09:38:46 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=31, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=912400, encodeId=1980912400b1, content=9300+的稿号，终于在12.29号接收了，本来图快选择了BBRC，可由于疫情，硬是投稿后40天再underview，然后3天后接受，总的来说，还是快呢，祝各位战友捷报频频，喜讯不断啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Dec 31 00:49:21 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116850, encodeId=7ab52116850ec, content=审稿速度:1.0 偏重的研究方向：离子通道;毒理学 经验分享：实时更新 2.14 submitted to journal 2.21 under review 2.28 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Tue Feb 28 09:18:32 CST 2023, time=2023-02-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1015358, encodeId=84211015358e1, content=偏重的研究方向：自噬 经验分享：8月20投稿，所有作者都已确认，4600+，还在with editor，一点点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01451679623, createdName=叮咚_MH, createdTime=Tue Sep 07 13:55:49 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0 经验分享：1.18投稿，2周后写了催稿信，2.11退回，要求润色并上传WB原图，2.18号重新提交，(附了邮件说明)，2.22 under review，2.24接收。很不好意思中间写了两次催稿信，但是真的心急如焚，很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了，果然是神刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109975, encodeId=4cba21099e578, content=9号投了，还在Submitted to Journal，大家最近投的怎么样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34518482526, createdName=ms6000001140416710, createdTime=Thu Jan 12 17:29:16 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=924823, encodeId=b27292482306, content=审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBWKOYYZkkamcYfia72BYMTLzRawUqBBnXP5S9zZWyRAkBjh2zHeKlvxAFOFNCksViaia2T8ykE5cgw/132, createdBy=4f922298321, createdName=zzzhanbin, createdTime=Tue Feb 16 00:16:17 CST 2021, time=2021-02-16, status=1, ipAttribution=)]

2021-02-16 zzzhanbin

审稿进度分享楼（已经审过稿的同仁，分享一下大致编号）

171 26

展开26条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务